Literature DB >> 20025367

A stress-coping profile of opioid dependent individuals entering naltrexone treatment: a comparison with healthy controls.

Scott M Hyman1, Kwang-Ik A Hong, Tara M Chaplin, Zubaida Dabre, Allison D Comegys, Anne Kimmerling, Rajita Sinha.   

Abstract

BACKGROUND: Stress is known to increase addiction vulnerability and risk of relapse to substance use. PURPOSE &
METHOD: We compared opioid dependent individuals entering naltrexone treatment (n = 57) with healthy controls (n = 75) on measures of stress, coping, and social support and examined the relative contribution of group membership, coping, and social support to stress within the sample. Analyses of variance (ANOVA) and covariance (ANCOVA), and stepwise multiple regression were conducted.
RESULTS: Compared with controls, opioid dependent subjects reported greater stress, less use of adaptive coping, but comparable use of maladaptive/avoidant coping. No group differences were found with respect to social support. Perceived stress was predicted by group membership, low social support, and greater use of maladaptive/avoidant coping, and the prediction by social support and maladaptive/avoidant coping did not differ by group.
CONCLUSION: Opioid dependent individuals entering naltrexone treatment experience higher levels of stress and report less use of adaptive coping strategies when compared with controls. Group membership, maladaptive/avoidant coping, and social support independently contribute to perceived stress. Findings suggest that novel treatment approaches that decrease maladaptive/avoidant coping and improve social support are important aspects of decreasing stress during early recovery from opioid addiction. Copyright 2009 APA

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20025367      PMCID: PMC2802459          DOI: 10.1037/a0017324

Source DB:  PubMed          Journal:  Psychol Addict Behav        ISSN: 0893-164X


  32 in total

1.  Social support and resilience to stress: from neurobiology to clinical practice.

Authors:  Fatih Ozbay; Douglas C Johnson; Eleni Dimoulas; C A Morgan; Dennis Charney; Steven Southwick
Journal:  Psychiatry (Edgmont)       Date:  2007-05

2.  Coping in context: the role of stress, social support, and personality in coping.

Authors:  Anita DeLongis; Susan Holtzman
Journal:  J Pers       Date:  2005-12

3.  Social support and relapse: commonalities among alcoholics, opiate users, and cigarette smokers.

Authors:  B E Havassy; S M Hall; D A Wasserman
Journal:  Addict Behav       Date:  1991       Impact factor: 3.913

4.  Racial differences in coping with the need for kidney transplantation and willingness to ask for live organ donation.

Authors:  Shayna L Lunsford; Kit S Simpson; Kenneth D Chavin; Laura G Hildebrand; Lucia G Miles; Lilless M Shilling; Gilbert R Smalls; Prabhakar K Baliga
Journal:  Am J Kidney Dis       Date:  2006-02       Impact factor: 8.860

5.  Stress generation, avoidance coping, and depressive symptoms: a 10-year model.

Authors:  Charles J Holahan; Rudolf H Moos; Carole K Holahan; Penny L Brennan; Kathleen K Schutte
Journal:  J Consult Clin Psychol       Date:  2005-08

6.  A global measure of perceived stress.

Authors:  S Cohen; T Kamarck; R Mermelstein
Journal:  J Health Soc Behav       Date:  1983-12

7.  Confirmatory factor analysis of the COPE questionnaire on community drinkers and an alcohol-dependent sample.

Authors:  P A Hasking; T P S Oei
Journal:  J Stud Alcohol       Date:  2002-09

8.  Cumulative adversity and drug dependence in young adults: racial/ethnic contrasts.

Authors:  R Jay Turner; Donald A Lloyd
Journal:  Addiction       Date:  2003-03       Impact factor: 6.526

9.  Childhood maltreatment, perceived stress, and stress-related coping in recently abstinent cocaine dependent adults.

Authors:  Scott M Hyman; Prashni Paliwal; Rajita Sinha
Journal:  Psychol Addict Behav       Date:  2007-06

Review 10.  Cognitive processes during fear acquisition and extinction in animals and humans: implications for exposure therapy of anxiety disorders.

Authors:  Stefan G Hofmann
Journal:  Clin Psychol Rev       Date:  2007-05-03
View more
  10 in total

Review 1.  Buprenorphine-mediated transition from opioid agonist to antagonist treatment: state of the art and new perspectives.

Authors:  Paolo Mannelli; Kathleen S Peindl; Tong Lee; Kamal S Bhatia; Li-Tzy Wu
Journal:  Curr Drug Abuse Rev       Date:  2012-03

2.  Psychological and physiological stress negatively impacts early engagement and retention of opioid-dependent individuals on methadone maintenance.

Authors:  Kellie M Jaremko; Robert C Sterling; Elisabeth J Van Bockstaele
Journal:  J Subst Abuse Treat       Date:  2014-08-29

3.  Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia.

Authors:  Evgeny Krupitsky; Edwin Zvartau; Elena Blokhina; Elena Verbitskaya; Marina Tsoy; Valentina Wahlgren; Andrey Burakov; Dimitry Masalov; Tatyana N Romanova; Vladimir Palatkin; Arina Tyurina; Tatyana Yaroslavtseva; Rajita Sinha; Thomas R Kosten
Journal:  Drug Alcohol Depend       Date:  2013-05-15       Impact factor: 4.492

4.  Noradrenergic synaptic function in the bed nucleus of the stria terminalis varies in animal models of anxiety and addiction.

Authors:  Zoé A McElligott; Megan E Fox; Paul L Walsh; Daniel J Urban; Martilias S Ferrel; Bryan L Roth; R Mark Wightman
Journal:  Neuropsychopharmacology       Date:  2013-04-03       Impact factor: 7.853

5.  Pharmacological enhancement of naltrexone treatment for opioid dependence: a review.

Authors:  Paolo Mannelli; Kathleen S Peindl; Li-Tzy Wu
Journal:  Subst Abuse Rehabil       Date:  2011-06

6.  The age of onset of substance use is related to the coping strategies to deal with treatment in men with substance use disorder.

Authors:  Maria Del Mar Capella; Ana Adan
Journal:  PeerJ       Date:  2017-08-15       Impact factor: 2.984

7.  Systemic and individual factors in the buprenorphine treatment-seeking process: a qualitative study.

Authors:  Valerie M Hewell; Angel R Vasquez; Inna D Rivkin
Journal:  Subst Abuse Treat Prev Policy       Date:  2017-01-11

Review 8.  Anti-stress neuropharmacological mechanisms and targets for addiction treatment: A translational framework.

Authors:  Mark K Greenwald
Journal:  Neurobiol Stress       Date:  2018-08-11

Review 9.  Friend of the Devil: Negative Social Influences Driving Substance Use Disorders.

Authors:  Matthew B Pomrenze; Franciely Paliarin; Rajani Maiya
Journal:  Front Behav Neurosci       Date:  2022-02-10       Impact factor: 3.558

Review 10.  Social defeat stress and escalation of cocaine and alcohol consumption: Focus on CRF.

Authors:  Emily L Newman; Michael Z Leonard; Danielle T Arena; Rosa M M de Almeida; Klaus A Miczek
Journal:  Neurobiol Stress       Date:  2018-09-19
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.